U.S. judge dismisses Teva lawsuits against Lilly on migraine drug
BOSTON: A federal judge recently dismissed a pair of patent infringement lawsuits by Teva Pharmaceutical Industries Ltd that sought to block Eli Lilly and Co from bringing its migraine drugEmgality to market in the United States.
U.S. District Judge Allison Burroughs in Boston said the lawsuits failed to raise an actual controversy that would allow her to rule in advance of the U.S. Food and Drug Administration's approving Lilly's product on whether it infringed Teva's patents.
The FDA approved Teva's own migraine drug, Ajovy, on Sept. 14.
Representatives for the companies did not immediately respond to requests for comment.
Read Also: Dr Reddy’s loses a patent case with Eli Lilly over Alimta
U.S. District Judge Allison Burroughs in Boston said the lawsuits failed to raise an actual controversy that would allow her to rule in advance of the U.S. Food and Drug Administration's approving Lilly's product on whether it infringed Teva's patents.
The FDA approved Teva's own migraine drug, Ajovy, on Sept. 14.
Representatives for the companies did not immediately respond to requests for comment.
Read Also: Dr Reddy’s loses a patent case with Eli Lilly over Alimta
Next Story
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd